Shandong Taibang Biological Products has received approval from the China State Food and Drug Administration (SFDA) to begin trials for its human fibrinogen to be used to treat congenital fibrinogen deficiency and acquired fibrinogen ...
Tags: clinical trials, fibrinogen deficiency, pharmaceutical product